Copertina di Pteridine reductase 1 as an antileishmanial drug target
Titolo del libro:

Pteridine reductase 1 as an antileishmanial drug target

Antifolate chemotherapy in leishmaniasis

VDM Verlag Dr. Müller (20.11.2009 )

Books loader

Omni badge eleggibile a buono
ISBN-13:

978-3-8364-9254-6

ISBN-10:
3836492547
EAN:
9783836492546
Lingua del libro:
Inglese
Risvolto di copertina:
Leishmaniasis is a major public health problem throughout much of the tropical and subtropical world. To date there is no vaccine against Leishmania and chemotherapy is the main weapon in our arsenal. There is an urgent need to identify novel chemotherapeutic targets and better drugs against Leishmania. In our search for effective antileishmanial lead molecules we have replaced empirical screening with rational drug design. Identifying suitable potential drug targets is essential for effective drug development. We have employed pteridine reductase 1 enzyme in Leishmania as one such target. Pteridine reductase 1 is a NADPH dependent short chain reductase responsible for the salvage of pterins in this protozoan parasite. This enzyme acts as a metabolic bypass for drugs targeting dihydrofolate reductase therefore for successful antifolate chemotherapy to be developed against Leishmania it must target both enzyme activities.
Casa editrice:
VDM Verlag Dr. Müller
Sito Web:
http://www.vdm-verlag.de
Da (autore):
Neeloo Singh
Numero di pagine:
180
Pubblicato il:
20.11.2009
Giacenza di magazzino:
Disponibile
categoria:
Genetica
Prezzo:
68,00 €
Parole chiave:
drug target, Leishmaniasis, Parasitic Disease, chemotherapy, Drug Development

Books loader

Newsletter

Adyen::amex Adyen::mc Adyen::visa Adyen::cup Adyen::unionpay Paypal Trasferimento

  0 prodotti nel carro d'acquisti
Modificare il carrello
Loading frontend
LOADING